Motivational interviewing in the management of type 2 diabetes mellitus

The effect of transtheoretical model–based motivational interview on self-efficacy, metabolic control, and health behavior in adults with type 2 diabetes mellitus: A randomised control study

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN15662612

Enrollment

Registered

2016-04-13

Start date

2014-01-08

Completion date

Unknown

Last updated

2021-11-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 diabetes mellitus Nutritional, Metabolic, Endocrine Type 2 diabetes mellitus

Interventions

Participants are randomly allocated to one of two groups. Intervention group: Participants undergo a 30 to 45 minute TTM-based motivational interview every 15 days or monthly, dependi

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Type 2 diabetes mellitus diagnosis for 6 months or longer with hypertension or dyslipidemia 2. Aged between 20 and 65 years 3. Primary school graduates 4. Body mass index (BMI) of 25 kg/m2 or more (overweight or obese) 5. Glycated hemoglobin (HbA1c) level of 7% or more 6. Using oral diabetic medication or insulin or both

Exclusion criteria

Exclusion criteria: 1. Medical problems that hinder exercise 2. Serious peripheral or autonomic neuropathy 3. Severe retinopathy 4. Psychiatric disorders

Design outcomes

Primary

Measure	Time frame
Self-efficiency is measured using the Self-Efficacy Scale at baseline and six months.	—

Secondary

Measure	Time frame
1. Metabolic values (glycated hemoglobin (HbA1c), weight, body mass index, and waist circumference) is measured taking intravenous blood in the laboratory at baseline and six months 2. Number of steps is measured using a pedometer at baseline and six months 3. Behavior change stage of nutrition, exercise, and medication use is measured using Diagnosis Form for Behavioral Change Stage in Patients with Type 2 Diabetes Mellitus at baseline and six months	—

Measure

Time frame

1. Metabolic values (glycated hemoglobin (HbA1c), weight, body mass index, and waist circumference) is measured taking intravenous blood in the laboratory at baseline and six months 2. Number of steps is measured using a pedometer at baseline and six months 3. Behavior change stage of nutrition, exercise, and medication use is measured using Diagnosis Form for Behavioral Change Stage in Patients with Type 2 Diabetes Mellitus at baseline and six months

—

Countries

Turkey

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026